These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 10342995
1. The Dietary Supplement Health and Education Act. Young AL, Bass IS. Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995 [No Abstract] [Full Text] [Related]
2. Re-thinking the dietary supplement laws and regulations 14 years after the Dietary Supplement Health and Education Act implementation. Jiang T. Int J Food Sci Nutr; 2009 Jun; 60(4):293-301. PubMed ID: 19085198 [Abstract] [Full Text] [Related]
5. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products. Kaczka KA. J Contemp Health Law Policy; 2000 Jun; 16(2):463-99. PubMed ID: 10970182 [No Abstract] [Full Text] [Related]
6. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994. Seamon MJ, Clauson KA. J Herb Pharmacother; 2005 Jun; 5(3):67-86. PubMed ID: 16520299 [Abstract] [Full Text] [Related]
7. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division. Villafranco JE, Lustigman AB. Food Drug Law J; 2007 Jun; 62(4):709-25. PubMed ID: 18557227 [No Abstract] [Full Text] [Related]
8. Regulation of dietary supplements: five years of DSHEA. Khatcheressian LA. Food Drug Law J; 1999 Jun; 54(4):623-44. PubMed ID: 11824458 [No Abstract] [Full Text] [Related]
9. The Food and Drug Administration's actions on ephedra and androstenedione: understanding their potential impacts on the protections of the Dietary Supplement Health and Education Act. Siegner AW. Food Drug Law J; 2004 Jun; 59(4):617-28. PubMed ID: 15880877 [No Abstract] [Full Text] [Related]
12. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices. Helmanis AM. Food Drug Law J; 1996 Jun; 51(4):631-5. PubMed ID: 11797732 [No Abstract] [Full Text] [Related]
13. A global view of the First Amendment constraints of FDA. Carver KH. Food Drug Law J; 2008 Jun; 63(1):151-215. PubMed ID: 18561459 [No Abstract] [Full Text] [Related]
14. Protecting consumers in the wake of the U.S. Dietary Supplement Health and Education Act. Foote JC. J Allied Health; 2007 Jun; 36(1):57-60. PubMed ID: 17425193 [Abstract] [Full Text] [Related]
15. Dietary supplements of botanicals and other substances: a new era of regulation. McNamara SH. Food Drug Law J; 1995 Jun; 50(3):341-8. PubMed ID: 10343003 [No Abstract] [Full Text] [Related]
16. Influence of the dietary supplement health and education act on consumer beliefs about the safety and effectiveness of dietary supplements. Dodge T, Litt D, Kaufman A. J Health Commun; 2011 Mar; 16(3):230-44. PubMed ID: 21120738 [Abstract] [Full Text] [Related]
17. Pediatric marketing exclusivity--as altered by the Best Pharmaceuticals for Children Act of 2002. Cooper KJ. Food Drug Law J; 2002 Mar; 57(3):519-44. PubMed ID: 12710409 [No Abstract] [Full Text] [Related]
19. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers. Reichertz PS. Food Drug Law J; 1996 Mar; 51(3):355-65. PubMed ID: 11797712 [No Abstract] [Full Text] [Related]